옛 화면은 좌우로 밀어 볼 수 있습니다.

Publications

Projects :
Published Dates :
Select All
Genetic variants of the organic cation transporter 2 influence the disposition of metformin (BMRC, PRCDM)
Clin Pharmacol Ther. 84(5):559-62, 2008 Nov [LINK]
Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes. (PRCDM)
Xenobiotica. 2008 Sep;38(9):1252-62 [LINK]
2008-International
The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15. ()
Pharmacogenet Genomics. 2008 May;18(5):424-33. [LINK ]
2008-International
Effect of silymarin supplement on the pharmacokinetics of rosuvastatin. ()
Pharm Res. 2008 Aug;25(8):1807-14. [LINK]
2008-International
Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations. ()
Clin Chim Acta. 2008 Feb;388(1-2):68-72. [LINK]
2008-International
Identification and functional characterization of genetic variants of human organic cation transporters in a korean population (NRL)
Drug Metab Dispos. 2007 Apr;35(4):667-75 [LINK]
2007-International
Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters. (NRL, PRCDM)
DMD 34:1145�1151, 2006 [LINK]
2006-International
 1  2